Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Protelight Pharmaceuticals (Jiangsu) Co. Ltd. has one pending office action in Biotechnology & Pharmaceuticals. One examiner and one art unit are associated with the matter. KATAKAM, SUDHAKAR is the busiest examiner, with one pending matter, making the current prosecution activity concentrated in one examination relationship.
The profile supports a focused response plan directed to the action, the assigned art unit, and the examiner’s treatment of the pharmaceutical claims. No additional examiner or art-unit assignments appear. Counsel can concentrate on claim scope, technical support, and examiner-specific prosecution strategy for the single active matter.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KATAKAM, SUDHAKAR | 1 | 74.8% | +23.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18272989 | ANTIMICROBIAL PEPTIDE LIQUID COMPOSITION AND FORMULATION THEREOF | KATAKAM, SUDHAKAR | — |
| Art Unit | Apps |
|---|---|
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18272989 | ANTIMICROBIAL PEPTIDE LIQUID COMPOSITION AND FORMULATION THEREOF | KATAKAM, SUDHAKAR | 1658 | §103 | Final Rejection | — | Pending | Jan 30, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialProtelight Pharmaceuticals (Jiangsu) Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Sudhakar Katakam has the most, with 1 of Protelight Pharmaceuticals (Jiangsu) Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
